Health
Researchers identify potent small molecule TMPRSS2 inhibitor against SARS-CoV-2 – News-Medical.Net
A team of scientists from the USA and Canada has recently identified and characterized a novel small-molecule compound inhibitor of cellular serine protease TMPRSS2,…
A team of scientists from the USA and Canada has recently identified and characterized a novel small-molecule compound inhibitor of cellular serine protease TMPRSS2, which shows significant antiviral potency against emerging variants of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2). The study by researchers from the University of British Columbia, Cornell University College of Veterinary Medicine, and Université de Sherbrooke is currently available on the bioRxiv* preprint server.
…
-
Noosa News17 hours agoYoung voices shape Sunshine Coast’s future
-
Business16 hours ago2 Low Cost Active ASX ETFs to consider
-
Noosa News13 hours agoCopperString transmission line projected to cost almost $14b amid massive blowout
-
Noosa News16 hours agoSXSW Sydney Has Announced the First 40 Speakers That’ll Be Taking to the Stage at Its 2025 Conference